Table 3 Comparison of the clinical characteristics between patients with and without AKI (n = 60)
Characteristic | AKI (n = 11) | Non-AKI (n = 49) | P value |
|---|---|---|---|
Age (years) | 32 ± 6 | 30 ± 5 | 0.356 |
Primiparous (%) | 8 (72.7) | 28 (57.1) | 0.34 |
Cesarean section (%) | 11 (100.0) | 43 (91.8) | 1.000 |
NYHA III–IV (%) | 11 (100) | 38 (77.6) | 0.189 |
Hospitalization time (days) | 14 (8–23) | 11 (7–15) | 0.105 |
Hypertension (%) | 0 | 6 (12.2) | 0.221 |
Diabetes mellitus (%) | 0 | 4 (8.2) | 1.000 |
PPCM history (%) | 0 | 3 (6.1) | 1.000 |
Pregnancy-induced hypertension syndrome (%) | 0 | 5 (10.2) | 0.573 |
Preeclampsia (%) | 3 (27.3) | 4 (8.2) | 0.108 |
SBP (mmHg) | 112 ± 20 | 118 ± 17 | 0.334 |
DBP (mmHg) | 79 ± 16 | 76 ± 13 | 0.52 |
HR (bpm) | 106 ± 19 | 101 ± 20 | 0.408 |
Echocardiographic findings | |||
LVEF (%) | 29 ± 11 | 38 ± 13 | 0.026 |
Left ventricular thrombosis (%) | 3 (27.3) | 2 (4.1) | 0.039 |
LVEDD (mm) | 52 ± 8 | 47 ± 9 | 0.386 |
Electrocardiographic findings | |||
ST-T changes (%) | 10 (90.9) | 34 (69.4) | 0.259 |
QRS time (ms) | 88 ± 10 | 96 ± 23 | 0.397 |
QTc time (ms) | 457 ± 54 | 460 ± 37 | 0.803 |
Hemoglobin (g/L) | 126 ± 17 | 122 ± 16 | 0.485 |
Platelet (G/L) | 238 ± 82 | 267 ± 84 | 0.3 |
ALT (U/L) | 26 (13–83) | 21 (12–43) | 0.233 |
AST (U/L) | 27 (25.3–29.4) | 22 (16–31) | 0.097 |
Serum creatinine (μmol/L) | 79.5 (63.4–98.3) | 55.5 (52.95–65.75) | 0.016 |
BNP (pg/mL) | 2243 (1272–5000) | 546.55 (104.63–1403.75) | 0.001 |
Ventilator (%) | 3 (27.3) | 3 (6.1) | 0.069 |
IABP (%) | 1 (9.1) | 0 | 0.183 |
ECMO (%) | 1 (9.1) | 0 | 0.183 |
CRRT (%) | 2 (18.2) | 0 | 0.031 |
Diuretic (%) | 11 (100) | 49 (100) | 1.000 |
ACEI/ARB (%) | 7 (63.6) | 33 (67.3) | 1.000 |
β-blockers (%) | 6 (54.5) | 36 (73.5) | 0.216 |
Ivabradine (%) | 0 | 3 (6.1) | 1.000 |
Anticoagulation (%) | 6 (54.5) | 5 (10.2) | 0.001 |
Digoxin (%) | 10 (90.9) | 20 (40.8) | 0.006 |
Vasoactive agents (%) | 2 (18.2) | 1 (2.0) | 0.084 |